User profiles for J Stinson
Jennifer StinsonHospital for Sick Children Verified email at sickkids.ca Cited by 20542 |
Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and …
JN Stinson, T Kavanagh, J Yamada, N Gill, B Stevens - Pain, 2006 - Elsevier
The aim of this study was to systematically review the psychometric properties, interpretability
and feasibility of self-report pain intensity measures for children and adolescents for use in …
and feasibility of self-report pain intensity measures for children and adolescents for use in …
A systematic review of faces scales for the self-report of pain intensity in children
D Tomlinson, CL Von Baeyer, JN Stinson, L Sung - Pediatrics, 2010 - publications.aap.org
CONTEXT: Numerous faces scales have been developed for the measurement of pain
intensity in children. It remains unclear whether any one of the faces scales is better for a …
intensity in children. It remains unclear whether any one of the faces scales is better for a …
[HTML][HTML] Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework
Background Prognosis research aims to identify factors associated with the course of health
conditions. It is often challenging to judge the overall quality of research evidence in …
conditions. It is often challenging to judge the overall quality of research evidence in …
[PDF][PDF] Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non–small-cell lung cancer treated with …
…, DA Ramies, D Sebisanovic, JA Stinson… - Journal of clinical …, 2005 - researchgate.net
Purpose Epidermal growth factor receptor (EGFR) mutations have been associated with
tumor response to treatment with single-agent EGFR inhibitors in patients with relapsed non–…
tumor response to treatment with single-agent EGFR inhibitors in patients with relapsed non–…
[HTML][HTML] Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449
…, CA Callahan, L Fu, T Holcomb, J Stinson… - … England Journal of …, 2009 - Mass Medical Soc
<p id="p001">Medulloblastoma is the most common malignant brain tumor in children. Aberrant
activation of the hedgehog signaling pathway is strongly implicated in the development …
activation of the hedgehog signaling pathway is strongly implicated in the development …
Diverse somatic mutation patterns and pathway alterations in human cancers
Z Kan, BS Jaiswal, J Stinson, V Janakiraman, D Bhatt… - Nature, 2010 - nature.com
The systematic characterization of somatic mutations in cancer genomes is essential for
understanding the disease and for developing targeted therapeutics 1 . Here we report the …
understanding the disease and for developing targeted therapeutics 1 . Here we report the …
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
…, J Guillory, CS Rivers, CK Foo, D Bhatt, J Stinson… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an exceptionally aggressive disease with poor prognosis.
Here, we obtained exome, transcriptome and copy-number alteration data from …
Here, we obtained exome, transcriptome and copy-number alteration data from …
[HTML][HTML] Recurrent R-spondin fusions in colon cancer
…, BS Jaiswal, J Guillory, C Ha, GJP Dijkgraaf, J Stinson… - Nature, 2012 - nature.com
Identifying and understanding changes in cancer genomes is essential for the development
of targeted therapeutics 1 . Here we analyse systematically more than 70 pairs of primary …
of targeted therapeutics 1 . Here we analyse systematically more than 70 pairs of primary …
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
…, T Januario, CP Ahn, T Holcomb, K Pujara, J Stinson… - Science, 2009 - science.org
The Hedgehog (Hh) signaling pathway is inappropriately activated in certain human cancers,
including medulloblastoma, an aggressive brain tumor. GDC-0449, a drug that inhibits Hh …
including medulloblastoma, an aggressive brain tumor. GDC-0449, a drug that inhibits Hh …
Pharmacological management of chronic neuropathic pain–consensus statement and guidelines from the Canadian Pain Society
…, T Coderre, PK Morley-Forster, J Stinson… - Pain Research and …, 2007 - hindawi.com
Neuropathic pain (NeP), generated by disorders of the peripheral and central nervous system,
can be particularly severe and disabling. Prevalence estimates indicate that 2% to 3% of …
can be particularly severe and disabling. Prevalence estimates indicate that 2% to 3% of …